Amr Mekky

Dr. Amr Mekky

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2025 in Journal of Gastrointestinal and Liver Diseases
Verified
Journal Article
Open access
PDF file
YQYa-Bin Qi
Ya-Bin Qi
XLXiao-Ting Li
Xiao-Ting Li
QSQiao-Qiao Shao
Qiao-Qiao Shao
LXLu Xu
Lu Xu
WZWen-Jing Zhang
Wen-Jing Zhang
SDSong-Ze Ding
Song-Ze Ding
Background and Aims: Vonoprazan (Vo) and amoxicillin (Amx) dual therapy has shown promising results for Helicobacter pylori (H. pylori) eradication. However, its efficacy needs to be verified in an area with a high prevalence of both H. pylori and gastric cancer. It is also unknown if the modified Vo-Amx plus bismuth (Bis) regimen might increase the eradication rate. We aimed to investigate the efficacy and safety of Vo-Amx and Vo-Amx-Bis regimens, compared to bismuth-containing quadruple therapy (BQT) for H. pylori eradication, as well as factors that affect the curing rate. Methods: A total of 342 treatment-naïve H. pylori-infected patients were screened and 255 were enrolled and randomized into Vo-Amx, Vo-Amx-Bis, and BQT groups for treatment. H. pylori infection status was determined by 13C-urea breath test. The eradication rate and incidence of adverse events were assessed, and factors that might affect the curing rate were also analyzed. Results: In per-protocol (PP) analysis, H. pylori eradication rates in Vo-Amx, Vo-Amx-Bis, and BQT groups were 95.1%, 92.7%, and 90.4%, respectively (p>0.05). In intention-to-treat (ITT) analysis, eradication rates in Vo-Amx, Vo-Amx-Bis, and BQT groups were 91.8%, 89.4%, and 88.2%, respectively (p>0.05). The eradication efficacy of Vo-Amx and Vo-Amx-Bis groups was non-inferior to that of BQT group, and the incidence of side effects (including nausea, vomiting, anorexia, abdominal pain, diarrhea, palpitation, dizziness, and debilitation) was lower than that of BQT group (6.1% and 4.9%, vs 45.8%, respectively, p<0.001). Successful eradication was associated with lower body surface area (BSA) in BQT group (p 0.05). Conclusions: Efficacy of the two Vo-containing regimens was comparable and non-inferior to the BQT in this region, and could serve as the first-line regimen for H. pylori eradication, and reduced use of one antibiotic per each patient treatment in real-world clinical application.


27 October 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
AHAmro Hashish
Amro Hashish
ASAvanti Sinha
Avanti Sinha
AMAmr Mekky
Amr Mekky
YSYuko Sato
Yuko Sato
NMNubia R. Macedo
Nubia R. Macedo
MEM. El-gazzar
M. El-gazzar
Bordetella avium (BA) is one of many pathogens that cause respiratory diseases in turkeys. However, other bacterial species can easily overgrow it during isolation attempts. This makes confirming the diagnosis of BA as the causative agent of turkey coryza more difficult. Currently, there are two PCR assays for the molecular detection of BA. One is conventional gel-based PCR and the other is TaqMan real-time PCR (qPCR) assay. However, multiple pitfalls were detected in both assays regarding their specificity, sensitivity, and efficiency, which limits their utility as diagnostic tools. In this study, we developed and validated two TaqMan qPCR assays and compared their performance to the currently available TaqMan qPCR. The two assays were able to correctly identify all BA isolates and showed negative results against a wide range of different microorganisms. The two assays were found to have high efficiency with a detection limit of approximately 1 × 103 plasmid DNA Copies/mL with high repeatability and reproducibility. In comparison to the currently available TaqMan qPCR assay, the newly developed assays showed significantly higher PCR efficiencies due to superior primers and probes design. The new assays can serve as a reliable tool for the sensitive, specific, and efficient diagnosis of BA.

8 October 2026 in BMJ
Verified
Journal Article
Closed access
PDF file
SDSongze Ding
Songze Ding
YHYin Hang
Yin Hang
AMAmr Mekky
Amr Mekky
LWLiu-Yi Wang
Liu-Yi Wang
ZLZhaoshen Li
Zhaoshen Li

7 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AMAmr Mekky
Amr Mekky
*I*Mohamed Ramadan Issa
*Mohamed Ramadan Issa
AHAmro Hashish
Amro Hashish
WHWafaa Hassan
Wafaa Hassan
AEAli Elkholy
Ali Elkholy
MEMohamed Enany
Mohamed Enany
Campylobacter is considered to be the most leading bacterial cause of human gastroenteritis worldwide. Consumption of undercooked or contaminated chicken food is the main source of human campylobacteriosis. Although Campylobacter is a leading cause of gastroenteritis, data on the comparative virulence gene profiles of Campylobacter jejuni (C. jejuni) and Campylobacter coli (C. coli) from chicken and human sources in Egypt remain scarce. This study aimed to characterize the virulence genes profiles of both C. jejuni and C. coli isolated from chicken and human fecal samples in Ismailia governorate, Egypt. A total of 20 isolates of each species were screened for 15 virulence genes. All isolates carried virB11, iam, racR, and tetO. In chicken isolates, the prevalence of additional virulence genes was higher, with pldA, dnaJ, flaA, cdtB, ciaB, and wlaN detected in 100%, 100%, 100%, 80%, 60%, and 0% of C. jejuni isolates and 100%, 100%, 60%, 60%, 40%, and 20% of C. coli isolates, respectively. In contrast, human isolates showed a markedly lower prevalence, with dnaJ, flaA, and cdtB detected in 20% of C. jejuni and 40% of C. coli isolates, while pldA, ciaB, and wlaN were absent in all human isolates. qPCR revealed significantly higher expression levels of dnaJ, virB11, flaA, and iam in chicken isolates compared to human isolates, with mean fold changes of 11.5, 7.16, 5.39, and 3.72 for C. jejuni, and 8.34, 5.21, 2.84, and 2.5 for C. coli, respectively. Differential expression of racR, cdtB, and tetO was not significant. Ganglioside mimicry genes (Cst11, wlaN, Waac, ggt, and cgtB) were absent in all human isolates. These findings underscore the significant variability in virulence gene profiles between chicken and human Campylobacter isolates and highlight the importance of molecular characterization in risk assessment and epidemiological surveillance of Campylobacter infections.

18 September 2025 in Microbiology Research
Verified
Journal Article
Open access
PDF file
AMAmr Mekky
Amr Mekky
*I*Mohamed Ramadan Issa
*Mohamed Ramadan Issa
AHAmro Hashish
Amro Hashish
WHWafaa Hassan
Wafaa Hassan
AEAli Elkholy
Ali Elkholy
MEMohamed Enany
Mohamed Enany
Campylobacter species are considered to be the leading bacterial cause of human gastroenteritis globally. Consumption of undercooked or contaminated food, such as chicken, is the main cause of human campylobacteriosis. Despite this significant zoonotic link, comparative data on virulence determinants in Campylobacter isolates across avian and human sources remain limited. This study aimed to characterize the prevalence and expression of virulence determinants in Campylobacter jejuni and Campylobacter coli isolates from chicken and human sources in Ismailia governorate, Egypt. A total of twenty C. jejuni and C. coli isolates (ten of each species) were screened for 14 virulence genes using PCR. All isolates harbored virB11, iam, racR, and tetO. Chicken isolates exhibited a significantly higher prevalence: C. jejuni (chicken): pldA, dnaJ, flaA (100%), cdtB (80%), ciaB (60%), and wlaN (0%); C. coli (chicken): pldA, dnaJ (100%), flaA (60%), cdtB (60%), ciaB (40%), and wlaN (20%). In contrast, human isolates showed a markedly lower prevalence: C. jejuni (human): dnaJ, flaA, and cdtB (20%); C. coli (human): dnaJ, flaA, and cdtB (40%). Crucially, pldA, ciaB, and wlaN were absent in all human isolates. plda and dnaJ genes showed statistically significant prevalence differences. qPCR revealed a significant upregulation (p < 0.05) of dnaJ, virB11, flaA, and iam in chicken isolates compared to human isolates, with log2 fold changes of 3.52, 2.84, 2.43, and 1.90 for C. jejuni and 3.06, 2.38, 1.51, and 1.32 for C. coli. Differential expressions of racR, cdtB, and tetO were not significant, with log2 fold changes ranging from −0.51 to 0.14. Ganglioside mimicry genes (Cst11, wlaN, Waac, ggt, and cgtB) and the carbon storage regulator gene (csrA) were absent in all human isolates. These findings underscore the significant variability in virulence gene profiles in chicken and human C. jejuni and C. coli isolates and highlight the importance of molecular characterization in the risk assessment and epidemiological surveillance of Campylobacter infections.